High-dose chemotherapy with haematopoietic stem cell transplantation is associated with significant physical and psychosocial morbidity, potential mortality and slow...
Treatment regimens involving the monoclonal anti-CD20 antibody rituximab are the standard of care for patients with CD20-positive non-Hodgkin lymphoma (NHL). It has...